期刊文献+
共找到4篇文章
< 1 >
每页显示 20 50 100
H_2受体拮抗剂用于抑制由化疗引起的恶心呕吐的临床研究 被引量:5
1
作者 郑伟华 饶珈琦 +2 位作者 谢德荣 詹锋 张华 《肿瘤防治杂志》 2004年第11期1203-1205,共3页
基于含铂或中度以上致呕肿瘤化疗方案 ,应用 5 HT3 受体拮抗剂为基础的止呕方法 ,对 12 6例病理学确诊为晚期恶性肿瘤患者按 2∶1信封法随机分组进行跟踪治疗 ,研究组加用H2 受体拮抗剂和安定 ,而对照组加用地塞米松 ,并从疗效、不良... 基于含铂或中度以上致呕肿瘤化疗方案 ,应用 5 HT3 受体拮抗剂为基础的止呕方法 ,对 12 6例病理学确诊为晚期恶性肿瘤患者按 2∶1信封法随机分组进行跟踪治疗 ,研究组加用H2 受体拮抗剂和安定 ,而对照组加用地塞米松 ,并从疗效、不良反应、耐受性及安全性等方面对两分组加以分析比较。研究组对抑制急性恶心呕吐有效率为91 2 % ( 73 / 80 ) ,迟缓性恶心呕吐有效率为 87 5 % ( 70 / 80 ) ,而对照组分别为 71 7% ( 3 3 / 46)及 60 9% ( 2 8/ 46) ,两分组相比差异有统计学意义 ,P值分别为 0 0 0 4及 0 0 0 1;加救援治疗后 ,研究组总完全控制率 10 0 % ( 80 / 80 ) ,对照组仅70 % ( 2 8/ 46) ,两组间差异也有统计学意义 ,P =0 0 0 0。初步研究结果提示 ,以 5 HT3 受体拮抗剂为基础加H2 受体拮抗剂和安定的止呕方法对由含铂或中度以上致呕肿瘤化疗方案所引起的恶心呕吐有明显的抑制作用 ,尤其是在迟缓性呕吐方面 ,有效率高 ,不良反应小 ,患者有良好的耐受性及安全性。 展开更多
关键词 肿瘤/药物疗法 受体 组氨h2 恶心 呕吐 安定/治疗应用
下载PDF
Quranic Verse No. 8 of Surat Al-Jumu’ah Leads us to Describe Cancer and Determine Its True Cause (Part-III) 被引量:1
2
作者 Mahmoud Saad Mohamed El-Khodary 《CellBio》 2018年第3期35-49,共15页
Therapeutic strategies for destroying cancer cells by making its death programs run again. The normal cell passes through several stages (Accumulation stage, Detoxification stage, Formation of free radical stage and A... Therapeutic strategies for destroying cancer cells by making its death programs run again. The normal cell passes through several stages (Accumulation stage, Detoxification stage, Formation of free radical stage and Activation of nuclear factor kappa B stage and the shutting down of programs of cell death stage) to become a cancerous cell. The success of the therapeutic strategy to treat cancer depends on making either one or both programs of cell death run again. Shutting down one stage completely will be sufficient to stop the transformation of the natural cell into a cancerous cell, which eliminates the production of hydrogen peroxide, thus the activity of the NF-Kb will be inhibited. However, shutting down all stages is the most comprehensive therapeutic strategy and guarantees treatment success. 展开更多
关键词 CANCER therapeutic Strategy Accumulation DETOXIFICATION Enzymes Free Radicals Antioxidants h2O2 Glutathione NF-Kb SULFORAPhANE Flavonoid Cur CUMIN
下载PDF
How to Return the Death Programs of Cancer Cells to Work again and Cure Cancer within a Short Time?
3
作者 Mahmoud Saad Mohamed El-Khodary Sahar Ezeldien Hasan +4 位作者 Wael A. Hassan Maather M. El-Lamie Ismail A. M. Eissa Waleed F. Khalil Salah M. Aly 《CellBio》 2019年第2期17-39,共23页
Cancer is cell fleeing from death by blocking the intrinsic and extrinsic pathways of cell death programs. In the present work, the experimental formula was designed to remove these blockers. It was applied on 120 Swi... Cancer is cell fleeing from death by blocking the intrinsic and extrinsic pathways of cell death programs. In the present work, the experimental formula was designed to remove these blockers. It was applied on 120 Swiss albino mice which were inoculated intraperitoneally and subcutaneously with Ehrlich Ascites Carcinoma cells;1 × (106) cell/mouse. The activity of the cell death programs of the tumor was detected by measuring the volume of Ascites fluid, counting the number of dead cancer cells, measuring the size of the tumor, detecting the positive reaction of caspase enzyme in cancer cells and presence of macrophages and apoptotic bodies in tumor tissue. The experimental formula succeeded in removing the blockers of the cell death program in cancer cells returning the cell death program to work again. 展开更多
关键词 CANCER therapeutic Strategy Accumulation DETOXIFICATION Enzymes Free RADICALS Antioxidants h2O2 GLUTAThIONE NF-kB SULFORAPhANE Flavonoid Cur CUMIN
下载PDF
Basic fibroblast growth factor protects against influenza A virus-induced acute lung injury by recruiting neutrophils 被引量:3
4
作者 Keyu Wang Chengcai Lai +17 位作者 Tieling Li Cheng Wang Wei Wang Bing Ni Changqing Bai Shaogeng Zhang Lina Han Hongjing Gu Zhongpeng Zhao Yueqiang Duan Xiaolan Yang Li Xing Lingna Zhao Shanshan Zhou Min Xia Chengyu Jiang Xiliang Wang Penghui Yang 《Journal of Molecular Cell Biology》 SCIE CAS CSCD 2018年第6期573-585,共13页
Influenza virus (IAV)infection is a major cause of severe respiratory illness that affects almost every country in the world.IAV infections result in respiratory illness and even acute lung injury and death,but the un... Influenza virus (IAV)infection is a major cause of severe respiratory illness that affects almost every country in the world.IAV infections result in respiratory illness and even acute lung injury and death,but the underlying mechanisms responsible for IAV pathogenesis have not yet been fully elucidated.In this study,the basic fibroblast growth factor 2 (FGF2)level was markedly increased in H1N1 virus-infected humans and mice.FGF2,which is predominately derived from epithelial cells,recruits and activates neutrophils via the FGFR2-PI3K-AKT-NFKB signaling pathway.FGF2 depletion or knockout exacerbated influenzaassociated disease by impairing neutrophil recruitment and activation.More importantly,administration of the recombinant FGF2 protein significantly aUeviated the severity of IAV-induced lung injury and promoted the survival of IAV-infected mice.Based on the results from experiments in which neutrophils were depleted and adoptively transferred,FGF2 protected mice against IAV , infection by recruiting neutrophils.Thus,FGF2 plays a critical role in preventing IAV-induced lung injury,and FGF2 is a promising potential therapeutic target during IAV infection. 展开更多
关键词 influenza h1N1 virus recombinant FGF2 protein neutrophil recruitment FGFR2-PI3K-AKT-NFκB signaling therapeutic target
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部